Vimarsana
Biggest News Aggregation in the World

Page 2 - Prostate Cancer Program News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Prostate Cancer Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Prostate Cancer Program Today - Breaking & Trending Today

Dr Signoretti on the Development of Novel Biomarkers in RCC Using Tissue-Based Analyses - Vimarsana News

Dr Signoretti on the Development of Novel Biomarkers in RCC Using Tissue-Based Analyses

Sabina Signoretti, MD, discusses research into the development of novel spatial biomarkers in renal cell carcinoma utilizing tissue-based in situ analyses.

INmune Bio Inc.'s Chief Scientific Officer, Mark Lowdell, Ph.D. to Present Plenary Talk at International Society of Cell & Gene Therapy - Vimarsana News

INmune Bio Inc.'s Chief Scientific Officer, Mark Lowdell, Ph.D. to Present Plenary Talk at International Society of Cell & Gene Therapy

Presidential Plenary Lecture to be Presented Wednesday, May 31 at the ICST Opening Session BOCA RATON, Fla., May 24, 2023 --  INmune Bio Inc. announces that Mark Lowdell,... | June 11, 2023

INmune Bio, Inc. Announces FDA Clearance of IND Application for INKmune™, a Natural Killer Therapy, for a Phase I/II Trial in Metastatic Castration-Resistant Prostate Cancer - Vimarsana News

INmune Bio, Inc. Announces FDA Clearance of IND Application for INKmune™, a Natural Killer Therapy, for a Phase I/II Trial in Metastatic Castration-Resistant Prostate Cancer

Represents First Ever Natural Killer Immunotherapy trial in Metastatic Castration-Resistant Prostate CancerWebinar at 11AM ET on Friday, May 12. BOCA RATON, Fla., May 08, 2023 --... | May 8, 2023

Gift of Life gives American Valve & Hydrant president an award - Vimarsana News

Gift of Life gives American Valve & Hydrant president an award

The Gift of Life presented the American Valve & Hydrant president with an award that pays tribute to Jason Deli’s founder.

Cardiff Oncology Announces Plans for a Randomized Trial in Metastatic Colorectal Cancer (mCRC), Durability of Responses in Ongoing Phase 1b/2 Trial in mCRC and Additional Business Updates - Vimarsana News

Cardiff Oncology Announces Plans for a Randomized Trial in Metastatic Colorectal Cancer (mCRC), Durability of Responses in Ongoing Phase 1b/2 Trial in mCRC and Additional Business Updates

Next trial in RAS-mutated mCRC (ONSEMBLE) is a randomized Phase 2 trial to demonstrate onvansertib's contribution to SoC and position for a possible...